Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, Strengthening Science and Community Impact Through Equitable Research Practices. The report examines innovative research methods adopted by the Foundation’s partners to promote health equity in public health research through community-engaged research practices.
Wall Street pared early morning gains by midday Monday, as investor caution returned despite a temporary easing in U.S.-China trade tensions. While the initial market reaction was positive, especially in tech, enthusiasm faded as the trading session progressed.
Stay tuned for the market movements in the S&P500 index on Monday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Let’s dig into the relative performance of Humana (NYSE:HUM) and its peers as we unravel the now-completed Q4 health insurance providers earnings season.
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today released its 2024 Impact Report, showcasing the company’s dedication to improving health outcomes and supporting communities across the nation. The report underscores Humana's efforts to improve member outcomes, advance environmental sustainability, and foster a culture of belonging and well-being among its employees, while contributing to a more effective and equitable healthcare system.
Well, we started off great, at least. Pre-market futures got off to a roaring start after overseas markets expressed optimism that trade deals with the U.S. were nigh.
Stay informed about the performance of the S&P500 index in the middle of the day on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.
U.S. stocks staged a broad-based rally on Monday, snapping a volatile losing streak after President Donald Trump hinted at a more diplomatic approach to tariff negotiations.
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index.
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.
Health insurer stocks are trading higher after the market close on Monday following a report indicating the Trump administration will increase payment rates for Medicare insurers.
Humana Inc. (NYSE: HUM) will release financial results for the first quarter 2025 (1Q25) and host a live question-and-answer session on Wednesday, April 30, 2025. Additionally, the company will host an Investor Conference on Monday, June 16, 2025.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Elevance Health (NYSE:ELV) and the rest of the health insurance providers stocks fared in Q4.
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Humana Inc. (NYSE: HUM) on behalf of long-term stockholders following a class action complaint that was filed against Humana on June 3, 2024 with a Class Period from July 27, 2022, to January 24, 2024. Our investigation concerns whether the board of directors of Humana have breached their fiduciary duties to the company.
Over the past six months, Humana’s shares (currently trading at $268.69) have posted a disappointing 15.2% loss while the S&P 500 was down 1.4%. This might have investors contemplating their next move.
